Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil
Not Applicable
Completed
- Conditions
- Acute Otitis MediaUpper Respiratory Infection
- Interventions
- Dietary Supplement: Lactobacillus rhamnosus GG
- Registration Number
- NCT02110732
- Lead Sponsor
- Helsinki University Central Hospital
- Brief Summary
The purpose of this study is to evaluate the effect of oral administration of probiotic Lactobacillus rhamnosus GG in middle ear and adenoid tonsil.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- recurrent otitis media
- secretory otitis media
- chronic rhinitis
- recurrent sinusitis
Exclusion Criteria
- significant illness
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Lactobacillus rhamnosus GG Lactobacillus rhamnosus GG Lactobacillus rhamnosus GG 8-9 x 10 -9 pmy 2x2 for 3 weeks Crystalline cellulose Lactobacillus rhamnosus GG Crystalline cellulose
- Primary Outcome Measures
Name Time Method Lactobacillus Rhamnosus GG in Middle Ear Effusion and Adenoid Tonsil After 3 weeks of oral consumption Presence of Lactobacillus rhamnosus GG in middle ear effusion of children having tympanostomy after oral administration of L. GG.
- Secondary Outcome Measures
Name Time Method Presence of Bacterial Pathogens in Middle Ear Effusion Samples After 3 weeks of oral consumption Association of Lactobacillus rhamnosus GG with occurrence of bacterial pathogens in the middle ear.
Presence of Rhinovirus and Enterovirus in Middle Ear Effusion Samples After 3 weeks of oral consumption Association of Lactobacillus rhamnosus GG with occurrence of viral pathogens in the middle ear.